| Felicia Catching, CNS | |
|
1905 Mission 66 # B, Suite 4, Vicksburg, MS 39180-3751 | |
| (601) 456-3047 | |
| Not Available |
| Full Name | Felicia Catching |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 1905 Mission 66 # B, Vicksburg, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801142708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 7777777 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Felicia Catching, CNS 231 B W Ranch Rd, Florence, MS 39073-8443 Ph: (601) 456-3047 | Felicia Catching, CNS 1905 Mission 66 # B, Suite 4, Vicksburg, MS 39180-3751 Ph: (601) 456-3047 |
News Archive
Standing involves many different positions and a child might want to stand prone (tilted forward), upright or supine (supported from behind) and although each position offers specific benefits, they all offer greater weight bearing through a child's legs which helps to strengthen bones...
Infighting among Democrats over inclusion of a public plan in health care reform is turning disagreement between moderates and liberals into a "Democratic civil war" with outside groups taking part in the attacks, Politico reports.
Microscopic probes developed at Rice University have simplified the process of measuring electrical activity in individual cells of small living animals. The technique allows a single animal like a worm to be tested again and again and could revolutionize data-gathering for disease characterization and drug interactions.
Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
› Verified 5 days ago
Stacy Flowers, PMHNP-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 120 Holt Collier Dr Ste C, Vicksburg, MS 39183 Phone: 601-597-2362 |